Phenomic AI Companies
Phenomic AI uses artificial intelligence to analyze phenotypes in complex disease models, including high-content co-culture and 3D assays, to discover and optimize therapeutics directly against phenotypic assays. The company's drug discovery platform makes it easier for pharmaceutical companies to discover drugs.
Investors
.png)
.png)
Founded Date:
2017-01-01
Last Funding Type:
Seed
Headquarters:
Toronto, Ontario, Canada
Investors Number:
13.0
Technology:
Artificial Intelligence, Biotechnology, Information Technology, Machine Learning
Employee Number:
5
Industry:
BioTech & Health Care
Estimated Revenue:
$6 million
Last Funding Date:
2020-10-07
Funding Status:
Seed
Total Funding:
11391214.0